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Abstract
THE IMPACT OF ADOLESCENT NICOTINE EXPOSURE ON DRUG DEPENDENCE IN
ADULTHOOD
By Mai alajaji, B.Pharm.
A thesis submitted in partial fulfillment of the requirements for the degree of
Master of Science at Virginia Commonwealth University.
Virginia Commonwealth University, 2010
Major Director: M. Imad Damaj, Ph.D
Professor, Pharmacology and Toxicology
Nicotine is one of the first and most commonly abused drugs in
adolescence. According to The Center for Disease Control, every day more than
6000 adolescents try their first cigarette and over 3000 of them become daily
smokers. Smoking among adolescents is a strong predictor of future drug abuse
and dependence in adulthood. A number of studies has suggests that
adolescents pre-exposed to nicotine may suffer permanent disruption of the
brain’s reward systems through changes in dopamine receptor function. We
hypothesize that nicotine exposure during adolescence causes long lasting
neurobiological alterations that increase the likelihood of cocaine use in
adulthood. Furthermore, it activates a neurobiological mechanism that is shared
by many drugs of abuse, which will increase susceptibility to their rewarding
effects. The work in this thesis contributes to the further understanding of this
critical developmental period. Conditioned-place-preference, acute locomotor and
locomotor sensitization pardigms were used to examine changes in cocaine
sensitivity in adulthood. Testing was performed on adult ICR mice that were
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exposed to nicotine (0.1 or 0.5 mg/kg, S.C., b.i.d.) or saline during adolescence
(postnatal days 28 or 46) or adult (postnatal day 70). Data showed that a 7-day
exposure to the higher dose of nicotine (0.5 mg/kg) altered cocaine-induced
responses. In contrast, neither 1 day exposure nor a low dose of nicotine (0.1
mg/kg) elicited this effect. A follow-up study was undertaken to determine if this
enhancement generally applies to other drugs of abuse. Pre-exposure to
0.5mg/kg

nicotine

during

early

adolescence

demonstrated

significant

enhancement to morphine reward, but it failed to increase d-amphetamine
preference in a CPP model. Further research will be required in order to more
fully examine the mechanisms of action for the observed changes in cocaine
rewards. In summary, these findings suggest that early adolescent nicotine
exposure leads to changes in cocaine reward and sensitivity during adulthood in
both dose and duration matters. Indeed, the adolescent brain is uniquely
vulnerable to the effects of nicotine on subsequent drug reward.

1
Introduction
1.1. Adolescent development:
Adolescence, defined as approximately ages 12 to 18 in humans and 28 to
60 postnatal days in mice and rats, is the final developmental period leading to
adulthood (Spear, 2000). During this critical period a transition occurs from a
fully-dependent child to an independent adult. This transition involves many
changes in a variety of areas, such as physical growth, cognition, social skills,
physiology, and emotions. This development maturation allows the individual to
reach independence from parental care. Adolescence is generally associated with
puberty (sexual maturation). However, puberty can be exactly defined in
physiological terms; adolescence boundaries are less precisely defined and
include both psychological and social factors (Laviola, 2003). Furthermore,
adolescence stage is defined by certain behavioral changes observed in this time
frame including increases in social interaction, risk-taking and novelty or reward
seeking. These changes are universal across a variety of species (Spear, 2000).
Indeed, over fifty percent of adolescents exhibit an increase in risk-taking
behaviors such as novel experiences involving drugs, alcohol and sexual activity.
Usually, risky behavior is viewed as exciting and rewarding (Arnett 1992). Similar
to humans, adolescent mice have shown hyperactive behavior in novel
environments (Darmani et al., 1996).
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1.2. Adolescent Brain development:
The adolescent brain is unique and in a state of transition as it undergoes
marked maturation that may play a role in subsequent drug abuse (Spear 2000).
An adolescent brain is anatomically and neurochemically different from that of an
adult brain. The adult male brain is approximately 10% larger than an adolescent
brain. Human MRI images have shown a linear increase in white matter and an
inverted U-shaped change in gray matter volume. Consequent to gray matter,
the synaptic connections increased during the early adolescent and rapidly
pruned back in late adolescence (Giedd, 2004). The adolescent brain goes
through an increase in myelination and synaptic pruning to allow more efficient
neural signaling. It has been predictable that as many as 50% of the average
number of synapses are lost during adolescence. This appears to be associated
with the marked maturation. One reason for synapse elimination is to decrease
unnecessary excitatory stimuli to the brain since many of the synapses in
adolescence are excitatory (Rakic et al. 1994). Moreover, the adolescent brain
shows remarkable alterations in neurochemical transmission. Distinctively, the
mesocorticolimbic dopamine system goes through significant modeling during
adolescent periods .The balance between mesocortical and mesolimbic dopamine
systems varies across a variety of species (Spear 2000). These developments are
responsible for the integration of the external environment with internal drives to
produce motivated behavior (Chambers et al., 2003).The prefrontal cortex (PFC)
Volume decline is in humans (Sowell et al. 1999) and rats (Van Eden et al. 1990).
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Moreover, density of spines on pyramidal cells in the human PFC decline (Mrzljak
et al. 1990). Dopaminergic innervation of the prefrontal cortex increases in
density during adolescence peak at levels well above those seen earlier or later
in life (Lewis 1997; Brenhouse et al. 2008). Also, the DA transporters number
increase (Akbari et al. 1992).There is also a transient increase in the number of
DA receptors that has been reported (Seeman et al. 1987). In spite of that,
transformations of neural circuitry are not limited to the DA system, these
changes are thought to play a critical role in the rewarding and reinforcing
effects of many drugs of abuse, including nicotine and cocaine. These various
studies suggest that adolescence is a unique period of intense neurological
development, and many of the changes that are ongoing during this period may
contribute to a heightened susceptibility to substance abuse.
1.3. Adolescent Drug Use:
The age of adolescence is often the time for novelty seeking and risk
taking behaviors. It is also during this period that they are introduced to the
world of tobacco, alcohol, and illicit drugs. According to the National Survey on
Drug Use and Health (2007), about 2.8 million children, aged 12 and above have
tried illicit drugs for the first time. In fact, in 2006, the number of cocaine
initiates, or those who have tasted cocaine for the first time, reached about 918
adolescents a day (NSDUH, 2007). Based on epidemiological studies, adolescents
who are exposed to tobacco and alcohol at an early age are most likely to use
illicit drugs later on in their lives (Kandel and Logan, 1984). Furthermore, those

4
who started at an early age have a harder time quitting, thus leading to a
heavier consumption of illicit drugs, tobacco and alcohol (Breslau and Peterson,
1996). Individuals under the age of 15 who smoke cigarettes are eighty times
more likely to use illegal drugs as compared to those who don’t (Breslau and
Peterson, 1996). Epidemiological studies have lead to the hypothesis that
nicotine may serve as a “gateway” drug that leads to an increased likelihood of
dependence on other drugs (Kandel et al ,1992). Animal studies have been
conducted to evaluate the "gateway" theory, since it allows for a more controlled
experiment and can identify the underlying mechanism for the progression of
drug use. In contrast, epidemiological studies in humans have been unable to
control factors such as environment, genetics, and others that confound the
analysis.
When an adolescent is exposed to nicotine at an early age, it leads to a
neurochemical alteration that may persist into adulthood, thus enhancing further
the need to smoke (Adriani et al., 2003). In fact, changes in the
mesocorticolimbic dopaminergic signaling due to illicit drug use at an early age
can increase a person’s vulnerability to other classes of abused drugs (Trauth et
al., 2001).
1.4. Adolescent Smoking:
The long-term impact of tobacco use in adolescence is documented. 90%
of adult smokers report their first use of tobacco prior to age 18 (Chassin et al.
1990). Another study found that students who have tried a single cigarette by
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age 11 remain vulnerable to future smoking, up to 3 years later (Fidler et al.
2006). Over 6,000 teenagers begin smoking every day (American Lung
Association Statistics 2002). Initiating smoking during adolescence correlates
with greater addiction liability, higher daily consumption, and reduced likelihood
of quitting (Colby et al. 2000; Kandel and Chen 2000). Indeed, an adolescent
smoking only two to four cigarettes per week is at risk of becoming addicted in
early adulthood (Riggs et al. 2007). Among American adolescents the number of
smokers has been rising sharply since 1992, while the age of initiation for
smoking has been declining (Johnston et al. 1998). Nicotine, the primary
addictive component in tobacco, acts on the brain to produce both rewarding
and aversive effects (Castane et al. 2005). Many adolescents become dependent
on nicotine despite the fact that initial exposure to nicotine has been shown to
be unpleasant (Eissenberg and Balster 2000). Despite the fact that nicotine
reaches the brain rapidly, it does not have long lasting acute effects; the short
half-life of nicotine of only 1 to 2 hours is likely to contribute to its repeated and
consistent use (Viveros et al. 2006). Adolescent smoking is different than adult
smoking and occurs in stages. The average number of cigarettes smoked per day
is 5.2 among adolescent smokers aged 12 to 17(NHSDA ,2003). Adolescent
smokers also experience signs of withdrawal such as cravings, nervousness, and
the inability to concentrate (Rojas et al. 1998; Killen et al. 2001). Indeed, this
group of teenagers reports frequent unsuccessful attempts to quit due to
cravings and withdrawal symptoms (Johnson 1982; Biglan and Lichtenstein
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1984). Without a doubt, factors such as social pressure, environment, stress,
biological effects, reinforcing effects, and aversive withdrawal symptoms
contribute to an adolescent’s decision to maintain a regular level of smoking.
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Hypothesis
We hypothesize that nicotine exposure during adolescence causes long
lasting neurobiological alterations that increase the susceptibility to cocaine
reward in adulthood. Furthermore, it will activate a neurobiological mechanism
that is shared by many drugs of abuse, which will increase susceptibility to their
rewarding effects.
Dissertation Objectives
The research in this thesis focuses on the effects impact of adolescent
nicotine exposure on the subsequent behavioral of cocaine. Based on
preliminary data and previous literature, we hypothesized that adolescent who
are exposed to low doses of nicotine would demonstrate increased vulnerability
to cocaine reward as compared to adults. Our first specific aim was to
characterize the impact of the effects of nicotine exposure during adolescence
with regards to cocaine. Both dose and duration of nicotine exposure were
investigated. Rewarding effects, changes in locomotor activity and locomotor
sensitization to cocaine were evaluated. The second and final specific aim was to
examine whether adolescent nicotine exposure effect generalizes to other
typically-abused drugs such as morphine and amphetamine.
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Materials and Methods
2.1. Subjects
Experimentally, naïve male adolescents and adult ICR mice were
purchased from Harlan Laboratories (Indianapolis, IN.). ICR mice are an outbred strain which have been used extensively in pharmacological studies.
Adolescent animals were obtained from different litters to avoid any effects that
may have confounded the result. Adolescent mice have been classified by the
use of three age intervals, early adolescence (PND 28-to-34), middle adolescence
(PND 34-to-46), and late adolescence (PND 47-to-59), (Spear 2000; Laviola
2003). These divisions are based on the similarities in physical, sociological, and
biological development in both rodents and humans. These divisions have been
carefully assessed in rodents and are assumed to correlate well with aspects of
human adolescence. For all studies, adolescent mice arrived on postnatal day
(PND) 21 and weighed approximately 18-23 grams at the start of the
experiment; adult mice arrived on PND 65 and weighed approximately 30-35
grams. The animals were housed in groups of four mice per cage, and allowed to
acclimate for seven days, the cages had small houses and toys. The mice were
handled for three days prior to the experiment with unlimited access to food and
water, except during the experimental sessions. All mice were housed in a
humidity and temperature controlled (22 °C) vivarium on a 12-hr light/dark cycle
(lights on at 6 a.m., off at 6 p.m.). Testing was conducted during the light phase
of the cycle. At the end of each experiment, the animals were euthanized by
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way of CO2 inhalation. Animals were maintained in a facility approved by the
American Association for Accreditation of Laboratory Animal Care, and all
procedures were approved by the Institutional Animal Care and Use Committee
of Virginia Commonwealth University.
2.2. Drugs
The drugs used in these experiments were (−)-Nicotine hydrogen tartrate
salt[(−)-1-methyl-2-(3-pyridyl)pyrrolidine (+)-bitartrate salt] and mecamylamine
hydrochloride [2-(methylamino) isocamphane hydrochloride], purchased from
Sigma-Aldrich Inc. (St. Louis, MO, USA); and d-amphetamine, morphine and
cocaine HCl, obtained from the Drug Supply Program of the National Institute on
Drug Abuse (Rockville, MD). All drugs were dissolved in 0.9% sterile saline
(0.9% sodium chloride) and prepared fresh before each experiment. All
compounds were injected subcutaneously (s.c.) except for the cocaine, which
was injected intraperitoneally (i.p.) at a volume of 10 ml/kg body weight. Doses
are expressed as the free base of the drug. Control groups received saline
injections at the same volume and by the same route.
2.3. Injection Protocol
Mice received nicotine during early adolescence (PND 28), middle
adolescence (PND 34), late adolescence (PND 47), or adulthood (PND 70+).
Based on previous work done by our lab, we choose to use either a short pattern
(one day) or a long pattern (7 days) of exposure. Depending upon the
experiment conducted, nicotine (0.1 and 0.5 mg/kg), cocaine (10 mg/kg), or
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saline was administered twice daily, with injections approximately 6 hours apart
(8 a.m. and 2 p.m.). After treatment, the adolescent mice were kept in their
home cages for 42 days to allow them to reach adulthood, at which point they
were evaluated in paradigms as described below. Adult mice were kept for
similar time periods as the adolescent mice.
2.4. Conditioned Place Preference
Conditioned place preference is a method which has been used widely to
evaluate the rewarding effects of a drug by pairing a drug with a particular
context (Bardo et al. 1995; Tzschentke 1998). Place conditioning boxes consisted
of two equal-sized compartments (20 cm long x 20 cm wide x 20 cm high),
separated by a grey central area with an opening that allowed access to either
side of the chamber. The opening in the partition could be closed off for pairing
days. The compartments have different-colored walls (one black, one white) and
distinct floor textures (grid rod floor in the black compartment and mesh in the
white one). The CPP protocol was conducted over the course of five days in an
unbiased fashion. The CPP procedure consisted of three phases: an initial
preference test, three conditioning days, and a final preference test. Animals
showing great initial preferences for one of the compartments were eliminated
from the study, because it is difficult to detect a shift in time spent in a
compartment when an animal had a strong initial bias prior to conditioning. This
is particularly important for drugs such as nicotine, which has a weak reinforcing
property.
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Handling habituation: On Friday through Sunday of the week prior to the start of
the place-conditioning procedure, mice in the CPP studies were handled once per
day for approximately two minutes each. Previous work done by our lab
demonstrated that handling experience plays an important role in the ability of
nicotine to produce a conditioned place preference (Grabus et al. 2006).

On day one: An initial preference test; animals were placed in the boxes and
allowed to roam freely from side to side for 15 minutes. Time spent in each side
was recorded using Med Associates interface and software. These data were
used to separate the animals into groups of approximately equal bias.

On day 2-4: Conditioning phase animals were paired for 20 minutes, the saline
group received saline on both sides of the boxes. Depending on the experiment,
the drug groups received nicotine, cocaine, morphine or d-amphetamines on
one side and saline on the opposite side of the boxes. Drug paired sides were
randomized among all groups. Conditioning lasted for three days, with animals in
the drug group receiving drugs each day.

On day 5: The final preference test was administered, no injections were given.
Animals were placed in the boxes and allowed to roam freely from side to side
for 15 minutes. The time spent on each side was recorded, and the data were
calculated based on time spent on the drug paired side minus time spent on the
saline paired side. An increase in time spent in the initially favored compartment
was indicated as a preference for the drug paired side, while a reduction or
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negative number indicated an aversion (CPA) to the drug paired side. A number
at or near zero indicated no partiality for either side.
2.5. Acute Locomotor Activity:
Pretreated mice were placed into individual Omnitech photocell activity
cages, (Columbus, OH; 28 x 16.5 cm), 10 minutes after the i.p. administration of
cocaine. Interruptions of the photocell beams, which assess walking and rearing,
were then recorded for the next 30 minutes. Data were computed as the number
of photocell interruptions.
2.6. Cocaine Locomotor Sensitization:
In this study, only early adolescent mice (PND 28) were used. Mice were
pretreated at adolescence with saline or nicotine (0.5 mg/kg) s.c. injections twice
daily for seven days; the injections were approximately six hours apart.

Our

protocol was based on the study completed by Biala, (2003). Once the mice
reached PND 70, a 13 day cocaine sensitization procedure was launched.

On Day 1: Mice received a saline injection (i.p.) and were then placed in
locomotor activity chambers for a 30 minute habituation period while activity
counts were recorded. Immediately the mice were removed from the locomotor
boxes and randomly divided into three groups: saline-saline, saline-cocaine, and
cocaine-cocaine (the group names represent the acquisition-day drug, followed
by the challenge day drug). The mice were then given another injection of either
saline or cocaine 20 mg/kg (i.p.), depending on their assigned group, and placed
in the chambers again for a 30-minute acquisition period.
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Days 2–5: The mice received an i.p. injection of either saline or cocaine 20
mg/kg, depending on their assigned group, and placed in the chambers again for
a 30-minute acquisition period.

Days 6–12: A drug-free week; the animals received no injections or exposure to
the chambers.

Day 13: Challenge day; the mice were tested again in the same way as described
for days 1–5, but the cocaine mice received a challenge-dose of cocaine of 5
mg/kg (i.p.). Counts were recorded for a 30-minute test period.
2.7. Statistical analysis
For all data, statistical analyses were performed using StatView ® (SAS,
Cary, NC, USA). Statistical analysis of all behavioral studies was performed with
mixed-factor ANOVA with post-hoc Tukey’s test when appropriate. P-values of
less than 0.05 were considered to be statistically significant.
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Studies
3.1 Methods

3.1.1. The Effect of Adolescent Nicotine Exposure on Cocaine-Induced
Conditioned Place Preference
Early adolescent mice (PND 28) and adults were divided into two groups.
One group received a short (1-day) nicotine exposure protocol, while the other
group received a long (7-day) protocol. Furthermore, each group was subdivided,
eight animals to each group. Two dose of nicotine were tested (0.1 or 0.5 mg/kg,
s.c.) As a control, adult ICR mice (PND=70) received the same treatment
protocol as the adolescents. When the adolescent mice reached young adulthood
(PND 70), and again at PND 112, they were tested for cocaine reward using
conditioned place preference. As previously described, mice have an initial

preference phase which is a drug-free assessment of baseline preference in a
three-compartment chamber. This is followed by a conditioning phase, which
includes three days of conditioning to cocaine (10 mg/kg i.p.). After the
conditioning period, the last day of the paradigm is the final preference phase,
during which preference is assessed. Preference scores are expressed as time
spent on the drug-paired side minus time spent on the saline-paired side. A
positive number indicated a preference for the drug-paired side, while a negative
number indicated an aversion to the drug-paired side. A number at or near zero
indicated no preference for either side.
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3.1.2. Influence of the Age of Nicotine Exposure on the Enhancement of Cocaine
Reward
Only late adolescent mice (PND 47) were used in this study. Mice were
injected with either nicotine (0.5 mg/kg s.c.) or saline twice a day for one week,
then put in their cages to reach adulthood. Once the adolescent mice had
reached PND 89, they were tested for cocaine reward using conditioned place
preference.

3.1.3. To Determine the Onset of the Cocaine Enhancement
For this study we used only early adolescent (PND 28) mice. The mice
were injected with either 0.5mg/kg nicotine or saline twice daily for a week. At
PND 36, the mice were tested for cocaine preference (10mg/kg, i.p.) as
described previously. Separate groups of mice received the same pretreatment
protocol and were tested for cocaine CPP at late adolescence (PND 50).

3.1.4. To Determine the Impact of the Sequential Order between Nicotine and
Cocaine
Early adolescent mice (PND 28) received cocaine (10mg/kg i.p.) or saline
twice daily for a week. Once adolescent mice had reached adulthood (PND 70),
they were tested for nicotine (0.5mg/kg s.c.) reward using conditioned place
preference.

3.1.5. To Determine if the Enhancement of Cocaine Reward by Nicotine is
Receptor –Mediated
Male ICR mice (PND 28) were randomly divided into groups: saline-saline,
mecamylamine-saline,

mecamylamine-nicotine

and

saline-nicotine

(groups

represent the first treatment followed by the second treatment). Depending on
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the group, mice were injected with mecamylamine (2mg/kg s.c.—a dose well
known to block most behavioral effects of nicotine in rodents), nicotine (0.5
mg/kg s.c.), or saline. At adulthood (PND 70), mice were tested for cocaine (10
mg/kg i.p.) reward using CPP animal model

3.1.6 Effect of Adolescent Nicotine Exposure on Morphine and AmphetaminInduced Conditioned Place Preference
To determine whether the early adolescent nicotine pretreatment effect
generalizes to other illicit drugs, adolescents, aged postnatal day 28, were given
two daily injections of saline or nicotine (0.5 mg/kg, s.c.). At PND 70, mice were
tested with a morphine (5mg/kg s.c.) reward, and another group were tested
with amphetamine (5mg/kg s.c) reward using conditioned place preference.

3. 1.7. Effects of Adolescent Nicotine Exposure on Cocaine-Induced Hyperactivity
Mice were tested for cocaine-induced hyperactivity using locomotor
chambers after reaching adulthood. For this study, early adolescent (PND 28)
and adult (PND 70) ICR male mice received 0.5 mg/kg nicotine or saline s.c.
injection twice daily for 7 days, with injections approximately 6 hours apart. On
PND 70 and 112 respectively, Mice were injected i.p with either saline or various
doses of cocaine (5, 10, and 20 mg/kg) and then placed into individual Omnitech
photocell activity cages (Columbus, OH; 28 x 16.5 cm) 10 minutes after injection.
Interruptions of the photocell beams, which assess walking and rearing, were
then recorded for the next 10 minutes. The data are expressed as the number of
photocell interruptions.
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3.2. RESULTS

3.2.1 Effect of Adolescent Nicotine Exposure on Cocaine-Induced Conditioned
Place Preference
Figures 1 and 2 show cocaine-induced CPP in nicotine pretreated mice
over all stages of adolescence and adulthood. It was important first to determine
the dose and length of nicotine exposure that is required to produce cocaine
enhancement in adulthood. Figures 1-a and 1-b show respectively the mice that
received either a short 1-day, or long 7-day exposure to nicotine during early
adolescence. All mice conditioned with cocaine in the CPP model developed
significant preference for the cocaine-paired side when compared to their
respective saline controls. An overall two-way ANOVA (pretreatment x exposure
duration) showed that only mice that had a 7-day exposure to the higher dose of
nicotine (0.5 mg/kg) displayed a significantly enhanced level of preference,
compared to those mice pretreated with saline. Interestingly, the short exposure
to nicotine failed to produce a significant enhancement of cocaine when
compared to the saline pretreated mice, even with the higher dose of nicotine.
Next, we wanted to determine the influence of the age of nicotine
exposure on the enhancement of cocaine reward. In Figure 1 and 2, age
differences were seen when cocaine was given (two-way ANOVA: age ×
pretreatment), with only early adolescents exhibiting greater preference in
response to 10 mg/kg of cocaine based on pretreatment status (shown in Figure
1-b). The results of cocaine-induced CPP following late adolescent and adult
nicotine exposure are shown in Figures 2-a and 2-b respectively. Neither late
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adolescent nor adult mice displayed any significant differences based on
pretreatment status in a 7-day exposure protocol.
Also, it was important to determine the onset of this enhancement.
Results from Figure 3-a and b show that significant enhancement peak in mice
tested in CPP model at PND 50 and continue to PND 70 (two-way ANOVA: age ×
pretreatment).In contrast, mice tested for cocaine-induce reward at PND 35
displayed approximately equal levels of preference for cocaine despite varying
pretreatment groups.
Moreover, we wanted to determine the impact of the sequential order
between nicotine and cocaine. Mice were pretreated with various dose of cocaine
(10 or 20 mg/kg) in early adolescence and conditioned with nicotine in the CPP
model in the adulthood. Results revealed that nicotine produced significant
preference in saline pretreated mice compare to saline control. On the other
hand, 10 and 20 mg/kg cocaine pre-exposure in adolescent mice demonstrated
no nicotine preference compared to saline pretreated mice (fig. 4).
Finally, determining if the enhancement of cocaine rewards or nicotine
rewards is receptor-mediated was a priority. Figure 5 shows that enhancement in
pretreated nicotine mice disappeared when mice received mecamylamine before
nicotine. Theses data suggest that early adolescence is the most critical stage for
cocaine-induced rewarding effects, and that this enhancement is affected by
dose and duration of nicotine exposure.
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a. 1-day exposure

*
*

*

b. 7-day exposure
*#

300

*

Preference Score( seconds)

250

*

200

saline
150

0.1mg/kg nicotine -19.2
218.64

100

0.5mg/kg nicotine

50
0
-50
saline

cocaine(10mg/kg )

Figure 1. Effects of early adolescent nicotine exposure on cocaine-induced CPP
in adulthood (a) 1-day (two injections) (b)7-day(14 injection).The y-axis
represents preference score and the x-axis expresses adolescent treatment in the
CPP paradigm. Each bar represents the mean ± SEM of seven to eight mice.
* p<.05 from respective saline control; # p<.05 from salaine-cocaine

20
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Figure 2. Effect of late adolescent and adulthood nicotine exposure on cocaineinduced reward. The y-axis represents preference score and the x-axis expresses
adolescent treatment in the CPP paradigm. A frequent pattern (7-day) of nicotine
exposure in late adolescence (a) and adulthood (b) was tested. Each bar represents
the mean ± SEM of eight mice. *p < 0.05 from respective saline control.

21
a. Early Adolescence
400

Preference Score( seconds)

350
300
250

*

200

*

saline
0.5mg/kg nicotine

150
100
50
0
-50
saline

cocaine(10mg/kg i.p)

b. Late Adolescence
#*

400

Preference Score( seconds)

350
300
250

*
saline

200

0.5mg/kg nicotine

150
100
50
0
saline

cocaine(10mg/kg i.p)

Figure 3. The Onset of the Cocaine Enhancement. The y-axis represents
preference score and the x-axis expresses adolescent treatment followed by
treatment in the CPP paradigm. a. CPP at early adolescence. b. CPP at late
adolescence . * p<.05 from respective saline control; # p<.05 from salinecocaine group in the same graph.
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Figure 4. The Effects of early adolescent cocaine exposure on nicotine-induced
CPA in adulthood. The y-axis represents preference score and the x-axis
expresses adolescent treatment in the CPP paradigm. Each bar represents the
mean ± SEM of seven to eight mice. *p<.05 from respective saline control;
# p<.05 from saline-nicotine.
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Figure 5. The Effects of early adolescent mecamylamine-nicotine exposure (7day) on cocaine-induced CPP in adulthood. The y-axis represents preference
score and the x-axis expresses adolescent treatment in the CPP paradigm. Each
bar represents the mean ± SEM of seven to eight mice.* p<.05 from respective
saline control; # p<.05 from saline-cocaine.
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3.2.2 Effect of Adolescent Nicotine Exposure on Morphine and AmphetaminInduced Conditioned Place Preference
Figure 6, shows that all mice, which were conditioned with morphine or
amphetamine in the CPP model, developed significant preference for the drugpaired side as compared to their respective saline controls. Interestingly, mice
which were pretreated with nicotine during adolescence and had morphine in
adulthood displayed a significantly enhanced level of preference as compared to
those mice which were pretreated with saline. In contrast to the morphine data,
the amphetamine (5 mg/kg) did not produce a significant enhancement of
reward.
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Figure 6. Effects of early adolescent nicotine exposure on morphine and
amphetamine-induced CPP in adulthood (a) morphine (b) amphetamine. The yaxis represents preference score and the x-axis expresses adolescent treatment
in the CPP paradigm. Each bar represents the mean ± SEM of seven to eight
mice. * p<.05 from respective saline control; # p<.05 from saline-morphine.
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3.3.3. Effects of Adolescent Nicotine Exposure on Cocaine-Induced Hyperactivity
In this study, we examined the effects of early adolescent exposure to low
doses of nicotine (0.5mg/kg) on cocaine’s acute effects, using a locomotor
activity test. Figures 7 and 8 show the results of these studies. All age groups
displayed a dose-responsive increase in locomotor activity in when given cocaine.
No significant changes were observed after the short (one day) or long (seven
day) nicotine exposure protocol during early adolescence as compared to those
pretreated with saline. Figures 8-a and 8-b show the results from studies where
pretreatment occurred in adulthood. The results were the same, no significant
differences were seen based on the adult group that received pretreatment.
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a.

b.

Figure 7. Cocaine-induced hyperactivity following nicotine exposure in early
adolescence. Mice were pretreated with saline or nicotine during early
adolescence either acutely (1 day) or repeatedly (7 days) and were tested for
cocaine hyperactivity in adulthood. n=6/group .
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a.

b.

Figure 8. Cocaine-induced hyperactivity following nicotine exposure in Adulthood
Mice were pretreated with saline or nicotine during early adolescence either
acutely (1 day) or repeatedly (7 days) and were tested for cocaine hyperactivity
in adulthood. n=6/group.
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3.3.4 Effects of Adolescent Nicotine Exposure on Locomotor Sensitization to
Cocaine
In Figure 9, mice that received low doses of nicotine in adolescence are
depicted with solid bars while the mice pretreated with saline are displayed with
non-solid bars. During the acquisition period, mice that were treated with
cocaine (20 mg/kg) showed an increase in locomotor activity, as expected, with
no differences due to adolescent pretreatment (*p<.05 as compared to sal-sal).
On challenge day, two groups received an injection of cocaine i.p. (5 mg/kg).
Mice pretreated with both saline and nicotine and mice treated with cocaine,
during acquisition, displayed an enhanced locomotor activity compared to mice
treated with saline only. However, mice that were pretreated with nicotine in
adolescence demonstrated a significant increase in cocaine-induced locomotor
activity in comparison to the animals pretreated with saline. These results
established that we were able to induce locomotor sensitization to cocaine, and
that early adolescent nicotine exposure enhances this effect.
On challenge day two groups received an injection of cocaine i.p. (5 mg/kg).
Both saline and nicotine pretreated mice who were treated with cocaine during
acquisition displayed enhanced locomotor activity as compared to those mice
treated with saline during acquisition. However, mice which were pretreated with
nicotine in adolescence demonstrate a significant increase in cocaine-induced
locomotor activity as compared to saline pretreated animals. These results
established that we were able to induce locomotor sensitization to cocaine and
that early adolescent nicotine exposure enhances this effect.

30

sal-sal
sal-sal
sal-coc
sal-coc
coc-coc
coc-coc

Effect of Adolescent Nicotine Exposure
on Behavioral Sensitization to Cocaine
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Figure 9. Cocaine-sensitization in ICR male mice. Early adolescent mice were
pretreated with either saline (non-solid bars) or nicotine (solid bars) for 7 days
and were tested for cocaine-induced locomotor sensitization in adulthood.
Treatment groups are represented by acquisition drug-challenge drug in the
legend (ex. sal-coc = saline during acquisition and cocaine on challenge day)
*p<.05 from sal-sal control on the same day; # p<.05 from sal-coc group;
$p<.05 from saline pretreated coc-coc group.(done by Dena Kota)
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Discussion
We hypothesized that adolescent nicotine exposure causes long-lasting
neurobiological alterations that increase susceptibility to cocaine use in adulthood.
Furthermore, by activating a neurobiological mechanism shared by many
commonly abused drugs, the effect of pre-exposure to nicotine during
adolescence may enhance rewards derived from a variety of other substances,
which in turn may increase susceptibility to abuse these drugs.
The present study of nicotine use in adolescence finds that exposure to
nicotine enhances the experienced reward of cocaine, but this is dependent on
the dose ,the duration of nicotine exposure and the age of the subject. Our data
showed that a 7-day exposure to (0.5 mg/kg) nicotine during early adolescent
was able to alter cocaine-induced responses.

In contrast, neither a 1-day

exposure nor a lower dose of nicotine (0.1 mg/kg) was able to elicit this effect.
This suggests that a more chronic pattern of adolescent nicotine exposure is
required to induce lasting changes in subsequent behavioral responses. Since
data in our first experiment suggested early adolescence was a critical period for
nicotine reward, we decided to focus on this phase of development for
subsequent studies. Similar to the effects seen with reward, exposure of early
adolescent mice to nicotine also enhanced locomotor sensitization to cocaine in
adulthood. However, an enhancement of cocaine-induced hyperactivity did not
occur upon acute or chronic injection of the drug in early adolescent and adult
mice pre-treated with nicotine.
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This differential enhancement of cocaine’s behavioral effects suggests that
nicotine

exposure

in

adolescence

has

an

impact

only

on

long-term

neuroadaptations after chronic/repeated administration to nicotine.

Our data

strongly suggest that nicotine intake during adolescence may act to crosssensitize the brain to cocaine’s long-term changes in the brain.
Many drugs of abuse share reward circuitry in the brain: the
mesocorticolimbic reward pathway, which has been implicated in many of the
rewarding and reinforcing effects of drugs of abuse (Nestler 2001; Kobb and Le
Moal 2001). This pathway originates in the ventral tegmental area and sends
projections to the nucleus accumbens (NAc) (Nestler 2001; Hyman and Malenka
2001). In fact, animals with lesions in these regions demonstrate a loss of drug
utilization (Robinson and Berridge 2001; Nestler 2004). Dopamine is the most
common and essential neurotransmitter involved in this pathway.
Azam et al. (2007) report that nicotine-stimulated dopamine release is
significantly higher during the early adolescent period in the male rat. Nicotine,
in particular, is able to activate VTA dopaminergic neurons directly via
stimulation of nicotinic cholinergic receptors, or indirectly via stimulation of its
receptors on glutamatergic neurons, which then innervate dopamine cells. Earlyadolescent nicotine exposure significantly elevates nAChR function in adulthood
(Kota 2009). Repeated stimulation by nicotine may promote maturation and
facilitate cocaine-induced plasticity of the mesocorticolimbic system. Our results
show that nicotine-induced enhancement of cocaine’s effects is mediated by
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neuronal nicotine receptors since mecamylamine, a nicotinic receptor antagonist,
blocked the enhancement. It is not clear which specific nicotinic subtypes are
blocked, because mecamylamine is a non-selective antagonist. Our data suggest
that the high preference of cocaine following nicotine pretreatment results from
activation of neuronal nicotinic receptors during the pretreatment phase, because
the enhancement “portion’’ of cocaine preference was blocked .
It is also clear from our results that the animals’ age of exposure has a
great impact. Indeed, nicotine exposure in early, but not late, adolescence
enhanced cocaine’s rewarding effects, suggesting that early adolescence is a
critical period for the behavioral plasticity induced by nicotine. Furthermore,
control animals receiving nicotine during adulthood did not show enhancement of
cocaine’s rewarding effects.
Finally, cross-sensitization to the rewarding effects of cocaine in the CPP
after nicotine pre-exposure was observed in late adolescence and continued to
adult age.

Although the time-course of this enhancement was not fully

determined, our results suggest that the behavioral plasticity observed is long
and may well extend beyond PND 70.
We have used an intermittent pattern of nicotine exposure over a brief
period (7-days), and a low dose of nicotine (0.5 mg/kg) that is known to produce
CPP. These protocols were selected in order to mimic patterns of adolescent
experimentation with cigarette smoking, namely short/acute and intermittent
exposure. The dose was administered by subcutaneous injection, which more
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closely mimics early teenage smoking. The pattern of adolescent smoking is
different to that of adults, as it occurs in stages. It usually involves repeated,
albeit irregular, use over an extended period. This ranges from 3 to 5 cigarettes
per week in an irregular manner for occasional and experimental smokers, to 3
to 5 cigarettes per week, every week, for regular smokers who might later move
to a state of nicotine dependence. In fact, some youths will advance to
dependence before leaving high school. The smoking pattern in adolescence is
further complicated by the fact that it is affected by specific events, such as
parties and weekends. Therefore, mimicking the human pattern of nicotine
exposure in an adolescent mouse model is not an easy task, since the
adolescence period in rodents is very short. We therefore chose a low dose
regimen (0.1 and 0.5mg/kg) and an intermittent pattern of nicotine exposure
over a short period (7-days) for our studies. Subcutaneous injection better
reflects the intermittent pattern of nicotine administration. Although oral
administration (nicotine in drinking water) of nicotine is stress free, the
absorption of nicotine is affected by the first pass metabolism, which leads to
variable absorption. For our studies, we have attempted to mimic the amount of
nicotine that an adolescent is exposed to daily, which is an equivalent of 5.2
cigarettes. A dose of 0.5 mg/kg of nicotine is comparable to the amount of
nicotine inhaled from smoking two to four cigarettes, (Benowitz N.L. ,1990).
Our data agree with a study conducted using rats where the investigators
utilized intravenous pre-treatments containing low doses of nicotine in
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adolescents over a four-day period, (McQuown, 2007). This nicotine exposure
resulted in an enhanced cocaine-sensitization response. Similarly, rats given
nicotine at PND 35 for 10 days showed an enhancement of cocaine-induced
reward using a CPP paradigm, (McMillen et al., 2005). Similar to our data on
cocaine sensitization, it has recently been shown that exposure to nicotine in
adolescent rats for seven days led to an enhanced sensitization to cocaine; as
opposed to those exposed only to saline, (McQuown, 2009).
In contrast, another study found that C57BL/6J mice demonstrated a
decline in cocaine-induced preferences, as measured by CPP after 25 days of
nicotine exposure in adolescents, (Kelley and Rowan, 2004). This inconsistency
could be due to the difference in mouse strain, C57BL/6J vs. ICR, as well as the
length of time of exposure. In addition, it was found that nicotine pre-exposure
led to an increase in cocaine’s motor activating effects, whereas our data
demonstrates no change in the acute locomotor study. Research has shown
mixed results regarding the effect of cocaine rewarding properties from nicotine
exposure in adolescents as compared to that of adults. It is clear that a number
of factors may be responsible for the differences between these studies; such as
species, drug dosage, length of pre-exposure, and timing of the testing. Since
any of the variables, or a combination thereof, may be responsible for the
difference in results; more work needs to be done to establish how the long-term
effects of adolescent nicotine exposure may be affected by these variables.
Exposure to nicotine during this period of brain development may lead to
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persistent, long lasting changes in the brain. Furthermore, the enhancement in
cocaine reward may be replicated with other drugs of abuse. A study done by
Kota et al. suggested early adolescent nicotine exposure significantly elevates
the nAChR function in adulthood in the brain. Indeed, pre-exposure to 0.5mg/kg
nicotine during early adolescence demonstrated significant enhancement to the
morphine’s reward, but it failed to increase d-amphetamine preference in a CPP
model (fig.6). Adolescent nicotine exposure has long-lasting effects on the
development of various pharmacological systems, specifically the dopaminergic
system. Amphetamine, cocaine (psychostimulants), morphine (opiates), and
nicotine

(cholinergic

agonists)

preferentially

increase

synaptic

dopamine

concentrations in the mesolimbic dopaminergic system (Di Chiara G). Cocaine
acts as an indirect dopamine agonist. It increases synaptic DA levels in the
nucleus accumbens via its actions at the DA transporter, inhibiting uptake into
the presynaptic terminals (Harris and Baldessarini, 1973). Morphine, through the
mu-opioid receptor activation, is known to excite dopamine neurons in the VTA
by the inhibition of the GABA-ergic inhibitory interneurons and, thereby,
increases dopamine transmission to the NAC (Rezayof et al., 2007).
The dopaminergic pathway is a likely candidate for observed crosssensitization as mentioned previously; many studies have shown that illicit drugs
tend to enhance dopamine transmission from the ventral tegmental area to the
nucleus accumbens (Koob and Le Moal, 1997. Dani, 2003). Also, other receptors
may be involved in our behavioral observations. Glutamatergic receptors are
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known to be involved in nicotinic effects as well. A study shows that adolescent,
but not adult, nicotine exposure down-regulated mGluR2/3 subunits in the
hippocampus and striatum. This same study also showed changes in NMDA
NR2A/B subunits regardless of the time of exposure, suggesting the involvement
of NMDA receptors in certain aspects of nicotine dependence (Adriani et al.
2004). These findings imply that other receptors may also be involved and
should be further examined.
Surprisingly, 10 mg. of cocaine pretreatment during early adolescence
demonstrates condition-place aversion to nicotine during adulthood. These
results may correlate with the establishment of drug dependence and an
increased risk of relapse after a period of withdrawal. They also further implicate
a role for dopamine in cross-sensitization to other drugs of abuse. Taken
together, our data suggests that adolescent nicotine exposure may cause
molecular alterations which lead to enhanced vulnerability to drug dependence
later in life. Preventing adolescent experimentation with tobacco is extremely
important as it can rapidly cause persistent changes in drug-induced behavioral
responses.
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Future Studies
Our findings suggest that early adolescent nicotine exposure results in
long-lasting alterations in behavioral response to cocaine and other drugs of
abuse in adulthood. The rewarding effects of cocaine and morphine are elevated
in a dose- and duration-dependent manner. In our studies, relatively low levels
of nicotine and short patterns of exposure during early adolescence resulted in
long-lasting changes in the rewarding properties of cocaine and morphine. Our
data imply that the adolescent brain is uniquely vulnerable to the effects of
nicotine on subsequent drug reward. Even short periods of exposure to cigarette
smoking, which are often seen in the adolescent population, could have longlasting and detrimental effects on smoking and drug abuse behavior.
Although drugs of abuse target several brain areas, enhanced dopamine
transmission from the ventral tegmental area (VTA) to the nucleus accumbens
(NAc) is a key element in the reward (Koob and Le Moal 1997; Dani 2003). It is
known that adolescent nicotine exposure has long-lasting effects on the
development of various pharmacological systems, and it is likely that the
dopaminergic system is one that is greatly affected. Since many drugs of abuse
are known to affect levels of dopamine in the brain, this pathway is a likely
candidate for the observed cross-sensitization. The mechanisms underlying this
“cross-sensitization” are still being elucidated, and additional studies would be
useful for determining these pathways. For example, nicotine may alter number
of dopamine receptors or function or level of dopamine transporters; therefore,

39
studies measuring DA receptor function and binding of DA ligands as well as DAT
binding should be conducted. Specifically, D1 and D2 ligands are of particular
interest.
These findings also raise the question of how exposure to secondhand smoke in
adolescence may affect sensitivity to drug abuse reward. We have shown that
relatively short periods of nicotine exposure and at low levels can cause
alterations in important regulatory systems. Children with parents or friends who
smoke may be exposed to levels of nicotine that can detrimentally affect the
development of neurological systems. These changes are likely to affect the
reinforcing and aversive properties of nicotine and other drugs of abuse and may
lead to increased vulnerability in these areas. The effect of exposure to
secondhand smoke on nicotine dependence in those children has yet to be
explored, and our results could have important implications for prevention
messages
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